tiprankstipranks
Trending News
More News >
Advertisement

GFLW - ETF AI Analysis

Compare

Top Page

GFLW

VictoryShares Free Cash Flow Growth ETF (GFLW)

Rating:74Outperform
Price Target:
GFLW, the VictoryShares Free Cash Flow Growth ETF, earns a solid overall rating thanks to several high-quality holdings with strong financial performance and growth potential, such as Lam Research, Nvidia, Broadcom, KLA, Royalty Pharma, and Amphenol, all benefiting from positive earnings trends and exposure to long-term themes like AI and biotechnology. However, some holdings like GE Vernova, Cardinal Health, and McKesson face valuation, leverage, or cash flow challenges, which slightly weigh on the fund’s rating. The main risk factor is the fund’s meaningful exposure to richly valued, growth-oriented names, where high expectations and sector-specific issues (such as export controls or financial leverage) could increase volatility.
Positive Factors
Strong Leading Holdings
Several of the largest positions, especially in technology and health care, have shown strong gains, helping support the ETF’s overall results.
Focused Growth Sectors
Heavy exposure to technology and health care gives investors targeted access to sectors that have been key drivers of market growth.
Growing Asset Base
The fund has built a sizable level of assets under management, suggesting it has attracted steady investor interest and liquidity.
Negative Factors
Recent Weak Performance
The ETF has shown weak returns over the past month, three months, and year to date, indicating recent performance headwinds.
High Sector Concentration
Nearly half of the portfolio is in technology stocks, which increases the risk if that sector experiences a downturn.
U.S.-Only Exposure
With almost all holdings in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market.

GFLW vs. SPDR S&P 500 ETF (SPY)

GFLW Summary

The VictoryShares Free Cash Flow Growth ETF (GFLW) tracks the Victory Free Cash Flow Growth Index, focusing on large U.S. companies that are growing the cash they generate from their businesses. It is heavily invested in technology and health care, and holds well-known names like Nvidia and Uber. Someone might consider this ETF if they want a simple way to invest in financially strong, growth-focused large companies while spreading risk across many stocks. A key risk is that it leans heavily toward growth and tech-related companies, so its price can rise and fall more than the overall market.
How much will it cost me?The VictoryShares Free Cash Flow Growth ETF (Ticker: GFLW) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it focuses on a specialized strategy targeting companies with strong free cash flow growth.
What would affect this ETF?The VictoryShares Free Cash Flow Growth ETF (GFLW), with its focus on U.S. large-cap companies and strong exposure to technology and consumer cyclical sectors, could benefit from continued innovation and growth in these industries, as well as favorable economic conditions like lower interest rates that support business expansion. However, it may face challenges from regulatory changes in the tech sector, economic slowdowns affecting consumer spending, or rising interest rates that could pressure growth-oriented companies. Monitoring sector trends and broader economic policies will be key for investors in this ETF.

GFLW Top 10 Holdings

GFLW is leaning heavily on U.S. tech, with chip makers like Lam Research and KLA doing much of the heavy lifting as their shares keep rising on AI-driven demand. Nvidia, once the star of the show, looks more mixed lately, losing some momentum even as its long-term story stays intact, while Broadcom has also been a bit soft, acting as a mild drag. Outside semis, Amphenol is quietly climbing, and health care names like Cardinal Health and Royalty Pharma are providing steadier ballast, giving this cash-flow-focused fund a tech-heavy but still diversified feel.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Lam Research4.07%$25.56M$294.12B184.63%
77
Outperform
GE Vernova Inc.3.32%$20.85M$216.20B118.21%
69
Neutral
Royalty Pharma3.29%$20.63M$26.07B39.65%
79
Outperform
Nvidia3.18%$19.99M$4.44T31.66%
76
Outperform
KLA3.13%$19.64M$191.91B95.02%
77
Outperform
McKesson3.02%$18.98M$114.50B57.45%
62
Neutral
Broadcom3.01%$18.88M$1.54T39.53%
76
Outperform
Cardinal Health2.99%$18.78M$51.96B74.94%
66
Neutral
Amphenol2.83%$17.79M$180.35B113.01%
78
Outperform
Comfort Systems2.63%$16.54M$47.19B241.99%
80
Outperform

GFLW Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
28.31
Negative
100DMA
28.37
Negative
200DMA
27.27
Positive
Market Momentum
MACD
-0.32
Positive
RSI
41.91
Neutral
STOCH
49.00
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GFLW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 27.92, equal to the 50-day MA of 28.31, and equal to the 200-day MA of 27.27, indicating a neutral trend. The MACD of -0.32 indicates Positive momentum. The RSI at 41.91 is Neutral, neither overbought nor oversold. The STOCH value of 49.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GFLW.

GFLW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$621.39M0.39%
$633.30M0.50%
$591.40M0.56%
$556.72M0.05%
$396.27M0.48%
$394.41M0.39%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GFLW
VictoryShares Free Cash Flow Growth ETF
27.28
1.52
5.90%
IWLG
IQ Winslow Large Cap Growth ETF
QDVO
Amplify CWP Growth & Income ETF
SFY
Sofi Select 500 Etf
LRGE
ClearBridge Large Cap Growth ESG ETF
FLCG
Federated Hermes MDT Large Cap Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement